Here a double-blinded, randomized (1:1), placebo-controlled trial using semaglutide 2.4 mg weekly (BARI-STEP) recruited adult participants at least 1 year after gastric bypass or sleeve gastrectomy with a suboptimal clinical response, defined as less than 20% weight loss from surgery
It activates receptors for both GLP-1 and GIP, leading to a powerful double whammy: Enhanced Insulin & Reduced Glucagon Tirzepatide significantly increases insulin production and lowers glucagon secretion, a hormone that raises blood sugar
After a couple of weeks of this I was ready to give up
This is particularly helpful for people who struggle to get good glycemic control with other medications or lifestyle changes
KPV calms inflammation at the cellular level, making it useful for gut issues, skin conditions, and autoimmune flare-ups
Do I need to exercise while taking these medications